Catalyst Pharmaceuticals (CPRX) Gross Profit: 2011-2025
Historic Gross Profit for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to $125.7 million.
- Catalyst Pharmaceuticals' Gross Profit rose 14.92% to $125.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.4 million, marking a year-over-year increase of 24.63%. This contributed to the annual value of $422.9 million for FY2024, which is 22.14% up from last year.
- Per Catalyst Pharmaceuticals' latest filing, its Gross Profit stood at $125.7 million for Q3 2025, which was down 0.17% from $125.9 million recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' Gross Profit registered a high of $125.9 million during Q2 2025, and its lowest value of $25.5 million during Q1 2021.
- In the last 3 years, Catalyst Pharmaceuticals' Gross Profit had a median value of $107.3 million in 2024 and averaged $104.0 million.
- Data for Catalyst Pharmaceuticals' Gross Profit shows a peak YoY surged of 102.75% (in 2023) over the last 5 years.
- Over the past 5 years, Catalyst Pharmaceuticals' Gross Profit (Quarterly) stood at $31.0 million in 2021, then skyrocketed by 60.08% to $49.6 million in 2022, then spiked by 91.19% to $94.8 million in 2023, then climbed by 26.82% to $120.2 million in 2024, then increased by 14.92% to $125.7 million in 2025.
- Its Gross Profit was $125.7 million in Q3 2025, compared to $125.9 million in Q2 2025 and $123.5 million in Q1 2025.